RPID - Rapid Micro Biosystems, Inc. Stock Price, Fair Value and News

$4.04-0.05 (-1.22%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

RPID Price Action

Last 7 days

-2.4%

Last 30 days

46.9%

Last 90 days

65.6%

Trailing 12 Months

288.5%

RPID RSI Chart

RPID Valuation

Market Cap

181.6M

Price/Earnings (Trailing)

-4.1

Price/Sales (Trailing)

5.95

EV/EBITDA

-1.86

Price/Free Cashflow

-4.71

RPID Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

RPID Fundamentals

RPID Revenue

Revenue (TTM)

30.5M

Rev. Growth (Yr)

3.08%

Rev. Growth (Qtr)

7.93%

RPID Earnings

Earnings (TTM)

-44.3M

Earnings Growth (Yr)

-1.61%

Earnings Growth (Qtr)

2.98%

RPID Profitability

EBT Margin

-223.27%

Return on Equity

-99.91%

Return on Assets

-52.47%

Free Cashflow Yield

-21.24%

RPID Investor Care

Shares Dilution (1Y)

2.95%

Diluted EPS (TTM)

-1.01

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	29.6M	30.3M	30.5M	0
2024	23.1M	24.7M	26.2M	28.1M
2023	18.0M	19.1M	20.6M	22.5M
2022	22.4M	20.1M	18.0M	17.1M
2021	17.9M	19.7M	21.4M	23.2M
2020	0	0	0	16.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, onsite technical training, and customer support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

CEO	Mr. Robert G. Spignesi Jr.
WEBSITE	rapidmicrobio.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	177

Rapid Micro Biosystems, Inc. Frequently Asked Questions

What is the ticker symbol for Rapid Micro Biosystems, Inc.? What does RPID stand for in stocks?

RPID is the stock ticker symbol of Rapid Micro Biosystems, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Rapid Micro Biosystems, Inc. (RPID)?

As of Wed Dec 03 2025, market cap of Rapid Micro Biosystems, Inc. is 181.62 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RPID stock?

You can check RPID's fair value in chart for subscribers.

Is Rapid Micro Biosystems, Inc. a good stock to buy?

The fair value guage provides a quick view whether RPID is over valued or under valued. Whether Rapid Micro Biosystems, Inc. is cheap or expensive depends on the assumptions which impact Rapid Micro Biosystems, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RPID.

What is Rapid Micro Biosystems, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, RPID's PE ratio (Price to Earnings) is -4.1 and Price to Sales (PS) ratio is 5.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RPID PE ratio will change depending on the future growth rate expectations of investors.